A Case of Severe Autoimmune Hemolytic Anemia After Receipt of First Dose of SARS-CoV-2 Vaccine

    July 2021 in “ International journal of laboratory hematology ”
    Tomas M Murdych
    Studysummary This report describes an 84-year-old man who developed severe autoimmune hemolytic anemia after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine, highlighting a potential, rare side effect without proving causation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →